Biontech Se ADR (BNTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 982,923 | 1,775,442 | 296,060 | 192,580 | 1,265,909 |
| Cost of Goods | 377,772 | 173,348 | 86,729 | 88,283 | 260,459 |
| Gross Profit | 605,151 | 1,602,094 | 209,331 | 104,297 | 1,005,450 |
| Operating Expenses | 1,009,082 | 1,657,264 | 778,909 | 667,254 | 848,491 |
| Operating Income | -403,159 | -54,821 | -568,849 | -562,674 | 157,418 |
| Interest Expense | 5,855 | 29,456 | 7,946 | 35,714 | 7,889 |
| Other Income | 117,642 | 113,150 | 119,650 | 129,159 | 170,626 |
| Pre-tax Income | -291,373 | 28,872 | -457,145 | -469,229 | 320,156 |
| Income Tax | 83,550 | 62,419 | -18,277 | -31,184 | 45,884 |
| Net Income Continuous | -374,923 | -33,547 | -438,868 | -438,045 | 274,272 |
| Net Income | $-374,923 | $-33,547 | $-438,868 | $-438,045 | $274,272 |
| EPS Basic Total Ops | -1.54 | -0.14 | -1.82 | -1.82 | 1.14 |
| EPS Basic Continuous Ops | -1.54 | -0.14 | -1.82 | -1.82 | 1.14 |
| EPS Diluted Total Ops | -1.54 | -0.14 | -1.82 | -1.82 | 1.15 |
| EPS Diluted Continuous Ops | -1.54 | -0.14 | -1.82 | -1.82 | 1.15 |
| EPS Diluted Before Non-Recurring Items | -0.38 | -0.14 | -1.82 | -1.82 | 1.15 |
| EBITDA(a) | $-224,880 | $93,517 | $-507,457 | $-517,585 | $334,077 |